SIGIRR and major depressive disorder: Earlier studies could not find significant changes in levels of SOCS1, TOLLIP, SIGIRR, or MyD88s in PBMC or monocytes of patients with MDD, but TNFAIP3 levels showed significant increase after treatment (14, 16).